Related Experiment Video
Updated: Jul 19, 2026

06:45
A Caenorhabditis elegans Nutritional-status Based Copper Aversion Assay
Published on: July 26, 2017
Dietary copper intake in artificially fed infants
Archives of Disease in Childhood
|November 1, 1986
Summary
Infant copper intake from formula is insufficient according to WHO guidelines. Current formulas and WHO recommendations for infant copper may need revision, as no significant growth differences were observed in infants with varying copper intakes.
Area of Science:
- Nutritional Science
- Pediatric Health
- Biochemistry
Background:
- Adequate copper and zinc intake is crucial for infant development.
- Existing World Health Organisation (WHO) guidelines recommend minimum copper intakes for infants.
Purpose of the Study:
- To assess infant copper and zinc status based on maternal levels and formula intake.
- To evaluate infant growth and health in relation to varying copper formula concentrations.
- To compare infant nutrient status with WHO recommended intakes.
Main Methods:
- Measured plasma copper and zinc, and leucocyte zinc in mothers and infants.
- Tracked 145 infants fed breast milk or one of two copper-varying formulas.
- Monitored infant growth and health at 2 months of age.
Main Results:
- No infants met WHO minimum copper intake recommendations.
- No significant differences in infant growth or health were observed across different copper intake groups.
- Infant birth weight correlated with maternal zinc status (plasma:leucocyte ratio).
- Maternal and umbilical cord plasma copper and zinc levels at birth were correlated.
- Higher copper formula intake led to low mean plasma zinc without increasing plasma copper.
Conclusions:
- Current infant formulas likely cannot meet WHO recommended minimum copper intakes.
- The WHO's minimum copper intake recommendations for formula-fed infants may be inaccurate.
- Maternal zinc status is a potential indicator of infant birth weight.
Related Concept Videos
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

